NDC 76420-080
Lidocaine Hydrochloride 10 mg per 1 mL injection, solution
On the label: Asclemed USA, Inc.. It's repackaged: Asclemed USA, Inc. rebottles it from AuroMedics Pharma LLC's NDC 55150-162.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Eugia Pharma Specialities Limited | Sangareddy, India | Makes it, tests it and packages it | Serious problems, FDA actionFeb 6, 2026 · 7 inspections, 2 with FDA action |
Repackaging site
- Asclemed USA Inc. dba Enovachem, Torrance, CA, United States · relabels it
Recalls
- Mar 28, 2019 · Class I · Aurobindo Pharma USA Inc.
Presence of Particulate Matter: One vial was found to contain a hair.
Lots: Lot #: CLC180117, Exp. June 2021
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Lidocaine: every company that makes it
- Form
- injection, solution, epidural; infiltration; intracaudal; perineural
- Strength
- 10 mg per 1 mL
- Approval
- ANDA ANDA203082
- On the market since
- Mar 14, 2013
- Package NDCs
76420-080-05- Official label
- DailyMed (National Library of Medicine), updated Apr 9, 2020
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?